Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Sodium-dependent dopamine transporter | ||
Ligand | BDBM50248035 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1281482 (CHEMBL3101940) | ||
Ki | >10000±n/a nM | ||
Citation | Hershberger, PM; Hedrick, MP; Peddibhotla, S; Mangravita-Novo, A; Gosalia, P; Li, Y; Gray, W; Vicchiarelli, M; Smith, LH; Chung, TD; Thomas, JB; Caron, MG; Pinkerton, AB; Barak, LS; Roth, GP Imidazole-derived agonists for the neurotensin 1 receptor. Bioorg Med Chem Lett24:262-7 (2013) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Sodium-dependent dopamine transporter | |||
Name: | Sodium-dependent dopamine transporter | ||
Synonyms: | DA transporter | DAT | DAT1 | Dopamine transporter (DAT) | Dopamine transporter protein (DAT) | Monoamine transporter | SC6A3_HUMAN | SLC6A3 | Sodium-dependent dopamine transporter | Sodium-dependent dopamine transporter (DAT) | Solute carrier family 6 member 3 | ||
Type: | Multi-pass membrane protein | ||
Mol. Mass.: | 68497.11 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q01959 | ||
Residue: | 620 | ||
Sequence: |
| ||
BDBM50248035 | |||
n/a | |||
Name | BDBM50248035 | ||
Synonyms: | (2S)-2-(1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-carboxamido)-4-methylpentanoic acid | CHEMBL508044 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H27ClN4O5 | ||
Mol. Mass. | 522.98 | ||
SMILES | COc1cccc(OC)c1-c1cc(nn1-c1ccnc2cc(Cl)ccc12)C(=O)N[C@@H](CC(C)C)C(O)=O |r,wD:29.32,(30.54,-1.43,;31.88,-2.19,;31.89,-3.73,;30.56,-4.51,;30.55,-6.06,;31.89,-6.83,;33.22,-6.06,;34.56,-6.82,;34.56,-8.36,;33.22,-4.5,;34.55,-3.73,;35.96,-4.35,;36.99,-3.2,;36.21,-1.87,;34.7,-2.19,;33.56,-1.17,;32.1,-1.66,;30.95,-.64,;31.26,.88,;32.73,1.36,;33.04,2.86,;34.49,3.34,;34.8,4.85,;35.65,2.32,;35.33,.81,;33.87,.33,;38.53,-3.36,;39.15,-4.76,;39.42,-2.1,;40.96,-2.26,;41.59,-3.65,;43.13,-3.81,;43.76,-5.2,;44.02,-2.56,;41.86,-1.01,;43.4,-1.16,;41.24,.4,)| | ||
Structure |